{"_id":"MONDO:0005674","_version":1,"ctd":{"chemical_related_to_disease":[{"cas_registry_number":"66376-36-1","chemical_name":"Alendronate","direct_evidence":"therapeutic","mesh_chemical_id":"D019386","pubmed":"15037971","source":"CTD"},{"cas_registry_number":"40391-99-9","chemical_name":"Pamidronate","direct_evidence":"therapeutic","mesh_chemical_id":"D000077268","pubmed":["15037971","15346059"],"source":"CTD"},{"chemical_name":"Zoledronic Acid","direct_evidence":"therapeutic","mesh_chemical_id":"D000077211","pubmed":["15037971","15346059"],"source":"CTD"}],"mesh":"D018212","pathway_related_to_disease":[{"inference_gene_symbol":"H3-3A","kegg_pathway_id":"hsa05034","pathway_name":"Alcoholism","source":"CTD"},{"inference_gene_symbol":"H3-3A","kegg_pathway_id":"hsa05202","pathway_name":"Transcriptional misregulation in cancer","source":"CTD"},{"inference_gene_symbol":"H3-3A","kegg_pathway_id":"hsa05322","pathway_name":"Systemic lupus erythematosus","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Hemostasis","react_pathway_id":"R-HSA-109582","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Meiosis","react_pathway_id":"R-HSA-1500620","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Signal Transduction","react_pathway_id":"R-HSA-162582","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Cell Cycle","react_pathway_id":"R-HSA-1640170","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Signaling by Rho GTPases","react_pathway_id":"R-HSA-194315","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RHO GTPase Effectors","react_pathway_id":"R-HSA-195258","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Signaling by Wnt","react_pathway_id":"R-HSA-195721","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"TCF dependent signaling in response to WNT","react_pathway_id":"R-HSA-201681","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Formation of the beta-catenin:TCF transactivating complex","react_pathway_id":"R-HSA-201722","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Gene Silencing by RNA","react_pathway_id":"R-HSA-211000","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Epigenetic regulation of gene expression","react_pathway_id":"R-HSA-212165","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"PRC2 methylates histones and DNA","react_pathway_id":"R-HSA-212300","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Cellular responses to stress","react_pathway_id":"R-HSA-2262752","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Condensation of Prophase Chromosomes","react_pathway_id":"R-HSA-2299718","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Oxidative Stress Induced Senescence","react_pathway_id":"R-HSA-2559580","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Senescence-Associated Secretory Phenotype (SASP)","react_pathway_id":"R-HSA-2559582","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Cellular Senescence","react_pathway_id":"R-HSA-2559583","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Metabolism of proteins","react_pathway_id":"R-HSA-392499","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"SIRT1 negatively regulates rRNA Expression","react_pathway_id":"R-HSA-427359","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression","react_pathway_id":"R-HSA-427389","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"NoRC negatively regulates rRNA expression","react_pathway_id":"R-HSA-427413","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription","react_pathway_id":"R-HSA-504046","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Positive epigenetic regulation of rRNA expression","react_pathway_id":"R-HSA-5250913","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"B-WICH complex positively regulates rRNA expression","react_pathway_id":"R-HSA-5250924","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Negative epigenetic regulation of rRNA expression","react_pathway_id":"R-HSA-5250941","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"DNA methylation","react_pathway_id":"R-HSA-5334118","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Transcriptional regulation by small RNAs","react_pathway_id":"R-HSA-5578749","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Activation of anterior HOX genes in hindbrain development during early embryogenesis","react_pathway_id":"R-HSA-5617472","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Activation of HOX genes during differentiation","react_pathway_id":"R-HSA-5619507","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RHO GTPases activate PKNs","react_pathway_id":"R-HSA-5625740","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3","react_pathway_id":"R-HSA-5625886","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Mitotic Prophase","react_pathway_id":"R-HSA-68875","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"M Phase","react_pathway_id":"R-HSA-68886","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Cell Cycle, Mitotic","react_pathway_id":"R-HSA-69278","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RNA Polymerase I Promoter Opening","react_pathway_id":"R-HSA-73728","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RNA Polymerase I Chain Elongation","react_pathway_id":"R-HSA-73777","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RNA Polymerase I Promoter Clearance","react_pathway_id":"R-HSA-73854","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"RNA Polymerase I Transcription","react_pathway_id":"R-HSA-73864","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Gene Expression","react_pathway_id":"R-HSA-74160","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Meiotic recombination","react_pathway_id":"R-HSA-912446","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Amyloid fiber formation","react_pathway_id":"R-HSA-977225","source":"CTD"},{"inference_gene_symbol":"H3-3A","pathway_name":"Factors involved in megakaryocyte development and platelet production","react_pathway_id":"R-HSA-983231","source":"CTD"}]},"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:0080001","DOID:0060085","DOID:200","DOID:65","DOID:0060123","DOID:4","DOID:0060099","DOID:17","DOID:0060072","DOID:0060094","DOID:7","DOID:14566"],"children":["DOID:1866"],"def":"\"A benign giant cell tumor that results_in the presence of multinucleated giant cells.\" [url:http\\://en.wikipedia.org/wiki/Giant_cell_tumor_of_bone]","descendants":["DOID:1866"],"doid":"DOID:4305","name":"bone giant cell tumor","parents":["DOID:200"],"synonyms":{"exact":["bone giant cell tumour","Giant cell neoplasm of bone","Giant cell tumor of bone","Giant cell tumour of bone"],"related":["giant cell myeloma","osteoclastoma"]},"xrefs":{"mesh":"D018212","ncit":"C121932","snomedct_us_2025_09_01":"697970009","umls_cui":"C0206638"}},"mondo":{"ancestors":["MONDO:0021581","MONDO:0000001","MONDO:0045024","MONDO:0003900","MONDO:0019060","MONDO:0004992","MONDO:0021054","MONDO:7770008","MONDO:0005089","MONDO:0005172","MONDO:0005070","MONDO:0002129","MONDO:7770006","MONDO:0023370","MONDO:0700096","MONDO:0002081","MONDO:0005381","MONDO:0000637"],"children":["MONDO:0006770"],"definition":"A benign but locally aggressive tumor that arises from the bone and is composed of mononuclear cells admixed with macrophages and osteoclast-like giant cells. It usually arises from the ends of long bones or the vertebrae. Clinical presentation includes pain, edema, and decreased range of motion in the affected joint. [NCIT:C121932]","descendants":["MONDO:0006770"],"label":"bone giant cell tumor","mondo":"MONDO:0005674","parents":["MONDO:0021054"],"synonym":{"exact":["benign bone giant cell tumor","benign bone giant cell tumour","GCT of bone","giant cell tumor of bone","giant cell tumor of bone (morphologic abnormality)","giant cell tumor of bone NOS (morphologic abnormality)","giant cell tumor of the bone","giant cell tumor, benign","giant cell tumour of bone (morphologic abnormality)","giant cell tumour of bone NOS (morphologic abnormality)","giant cell tumour of the bone","Osteoclastoma, benign"]},"xrefs":{"doid":["DOID:4305"],"efo":["EFO:0007176"],"gard":["0013046"],"hp":["HP:0011847"],"medgen":["64624"],"mesh":["D018212"],"ncit":["C121932"],"oncotree":["GCTB"],"orphanet":["363976"],"sctid":["697970009"],"umls":["C0206638"]}},"umls":{"_license":"https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/release/license_agreement.html","icd10am":{"preferred":"M9250/1"},"mesh":{"preferred":"D018212"},"nci":{"non-preferred":"C121932","preferred":"C121932"},"snomed":{"non-preferred":["57500000","189891002","697970009"],"preferred":["57500000","697970009"]},"umls":"C0206638"}}